CompletedNot Applicable

Efficacy of Herbal Galactagogue Silitidil After Preterm Birth

Germany106 participantsStarted 2017-08-14

Plain-language summary

After preterm birth mothers often suffer from hypogalactia. Herbal galactogogues can be used in order to increase milk production. In this double-blind, randomized, placebo-controlled clinical trial the effect of Silitidil, an extract from milk thistle, on the postpartal milk production in mothers of very premature newborns is investigated.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * mothers after preterm birth \<= 32 weeks of gestation * Age of the newborn 1 - 5 days * Human milk feeding intended Exclusion Criteria: * Ingestion of other galactagogues * maternal chronical disease requiring therapy (e.g. severe hypothyreosis, preexistent arterial hypertension, Type I or 2 Diabetes, chronic inflammatory bowel disease, severe bronchial asthma, pollinosis) * medication influencing prolactine levels * Mastitis at time of enrollment * mammary tumors or surgery influencing milk production

What they're measuring

Daily milk production (ml/24h) at end of Intervention period

Timeframe: 3 weeks after study initiation

Trial details

NCT IDNCT03577587

SponsorWaldkrankenhaus Protestant Hospital, Spandau

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-02-10

View on ClinicalTrials.gov More Breast Milk Production trials